Tag: PAS

Manufacturing Changes and Generic Approval: What Triggers FDA Re-Evaluation

Learn what manufacturing changes trigger FDA re-evaluation for generic drugs, including PAS submissions, approval timelines, costs, and how new programs are speeding up reviews for U.S.-made generics.